Page last updated: 2024-10-22

pimagedine and Multiple Myeloma

pimagedine has been researched along with Multiple Myeloma in 2 studies

pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erez, O1
Goldstaub, D1
Friedman, J1
Kahana, C2
Tobias, KE1

Other Studies

2 other studies available for pimagedine and Multiple Myeloma

ArticleYear
Putrescine activates oxidative stress dependent apoptotic death in ornithine decarboxylase overproducing mouse myeloma cells.
    Experimental cell research, 2002, Nov-15, Volume: 281, Issue:1

    Topics: Animals; Apoptosis; Blotting, Western; Calcium; Caspase 2; Caspases; Chelating Agents; Cytochrome c

2002
Exposure to ornithine results in excessive accumulation of putrescine and apoptotic cell death in ornithine decarboxylase overproducing mouse myeloma cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1995, Volume: 6, Issue:10

    Topics: Amine Oxidase (Copper-Containing); Animals; Apoptosis; Biogenic Polyamines; Cell Size; Cell Survival

1995